3.0
6 Sept 2015
Anonymous employee
Current employee, more than 10 years
South San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
"Patients first" and "science driven" are not just slogans, they are meaningful and motivating.
Cons
The ability to get things done has greatly eroded. Politics within and across functions have removed projects as the central focus. There are too many committees before decisions are made, which slows everything in the pipeline and portfolio. Leadership is average, used to be stellar. Is now an extremely risk averse environment, after Roche acquired Genentech. Benefits chiseled away every year. Even the price of food in cafeteria has risen - salmon, rice, carrots this week for lunch was over $10.